158 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
(rF1V) vaccine candidate adjuvanted with CpG 1018® currently in a Phase 2 clinical trial in collaboration with, and fully funded by, the U.S. Department … of Defense.
In March 2024, Dynavax and the U.S. Department of Defense executed a contract modification to add approximately $4 million to support CMC
8-K
EX-99.1
mavxbk1l
22 Feb 24
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
EX-99.1
dkdawrv6 ku
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
8-K
EX-99.2
wvqq lfenluif5d
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
8-K
EX-99.1
zaa4hvm4gvjhr6l mx
2 Nov 23
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:10pm
S-3ASR
k37aqlvae2hxz0
3 Aug 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
q37fxz v9
3 Aug 23
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:11pm
8-K
EX-99.1
6qdcbs3r bhigh6co8f
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
dzrd8
3 Nov 22
Dynavax Reports Third Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
gx3lu7
4 Aug 22
Dynavax Reports Second Quarter 2022 Financial Results
4:09pm